TGTX
TG Therapeutics Inc
Price:  
32.02 
USD
Volume:  
2,063,674.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX WACC - Weighted Average Cost of Capital

The WACC of TG Therapeutics Inc (TGTX) is 8.1%.

The Cost of Equity of TG Therapeutics Inc (TGTX) is 8.05%.
The Cost of Debt of TG Therapeutics Inc (TGTX) is 17.85%.

Range Selected
Cost of equity 6.90% - 9.20% 8.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 11.80% - 23.90% 17.85%
WACC 6.9% - 9.3% 8.1%
WACC

TGTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.65 0.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 11.80% 23.90%
After-tax WACC 6.9% 9.3%
Selected WACC 8.1%